glutathione infusion sydney Injection in Arcadia, Beverly Hills and Los Angeles County Glutathione IV Therapy - Sage
Description
Designed as a three-arm randomised, double-blind, placebo-controlled intervention trial, the ErgMS study will supplement participants with placebo, 5 or 30 mg/d ergothioneine for 12 weeks, taking measurements of metabolic syndrome risk factors, serum markers of oxidative stress (lipid peroxidation), inflammation, blood platelet function and liver function at baseline, and after 6 weeks and 12 weeks of supplementation (Reference Tian, Cioccoloni and Sier97)
Reducing the likelihood of severe illnesses
(2024) 10:e25680
one was the control, whereas the other was presented with the peptide
